Replies to post #10561 on GeoVax Labs Inc (GOVX)

[biznizz]

https://geovax.reportablenews.com/pr/geovax-reports-2019-third-quarter-financial-results-and-provides-corporate-update


HIV Preventive Vaccine – We are planning for a new Phase 1 human clinical trial with operational support from the HIV Vaccine Trials Network (HVTN) and funding from the National Institute of Allergy and Infectious Diseases (NIAID).